123 related articles for article (PubMed ID: 24670009)
1. Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.
Fox BM; Sugimoto K; Iio K; Yoshida A; Zhang JK; Li K; Hao X; Labelle M; Smith ML; Rubenstein SM; Ye G; McMinn D; Jackson S; Choi R; Shan B; Ma J; Miao S; Matsui T; Ogawa N; Suzuki M; Kobayashi A; Ozeki H; Okuma C; Ishii Y; Tomimoto D; Furakawa N; Tanaka M; Matsushita M; Takahashi M; Inaba T; Sagawa S; Kayser F
J Med Chem; 2014 Apr; 57(8):3464-83. PubMed ID: 24670009
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
3. Identification of 2-aminooxazole amides as acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) inhibitors through scaffold hopping strategy.
Kim HM; Smith MD; Kim JH; Caplen MA; Chan TY; McKittrick BA; Cook JA; van Heek M; Lachowicz J
Bioorg Med Chem Lett; 2013 Dec; 23(23):6410-4. PubMed ID: 24120540
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.
Zhou G; Ting PC; Wishart G; Zorn N; Aslanian RG; Lin M; Smith M; Walker SS; Cook J; Van Heek M; Lachowicz J
Bioorg Med Chem Lett; 2014 Apr; 24(7):1790-4. PubMed ID: 24618302
[TBL] [Abstract][Full Text] [Related]
5. Discovery and optimization of adamantane carboxylic acid derivatives as potent diacylglycerol acyltransferase 1 inhibitors for the potential treatment of obesity and diabetes.
Pagire SH; Pagire HS; Lee GB; Han SJ; Kwak HJ; Kim JY; Kim KY; Rhee SD; Ryu JI; Song JS; Bae MA; Park MJ; Kim D; Lee DH; Ahn JH
Eur J Med Chem; 2015 Aug; 101():716-35. PubMed ID: 26218650
[TBL] [Abstract][Full Text] [Related]
6. Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
Nakajima K; April M; Brewer JT; Daniels T; Forster CJ; Gilmore TA; Jain M; Kanter A; Kwak Y; Li J; McQuire L; Serrano-Wu MH; Streeper R; Szklennik P; Thompson J; Wang B
Bioorg Med Chem Lett; 2016 Feb; 26(4):1245-8. PubMed ID: 26804232
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
[TBL] [Abstract][Full Text] [Related]
8. ACAT-selective and nonselective DGAT1 inhibition: adrenocortical effects--a cross-species comparison.
Floettmann JE; Buckett LK; Turnbull AV; Smith T; Hallberg C; Birch A; Lees D; Jones HB
Toxicol Pathol; 2013; 41(7):941-50. PubMed ID: 23427273
[TBL] [Abstract][Full Text] [Related]
9. Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors.
DeVita RJ; Pinto S
J Med Chem; 2013 Dec; 56(24):9820-5. PubMed ID: 23919406
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
Kadam KS; Jadhav RD; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Srinivasan S; Devle J; Damre A; Nemmani KV; Gupte A; Sharma R
Eur J Med Chem; 2013 Jul; 65():337-47. PubMed ID: 23735282
[TBL] [Abstract][Full Text] [Related]
11. Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1.
Mougenot P; Namane C; Fett E; Camy F; Dadji-Faïhun R; Langot G; Monseau C; Onofri B; Pacquet F; Pascal C; Crespin O; Ben-Hassine M; Ragot JL; Van-Pham T; Philippo C; Chatelain-Egger F; Péron P; Le Bail JC; Guillot E; Chamiot-Clerc P; Chabanaud MA; Pruniaux MP; Schmidt F; Venier O; Nicolaï E; Viviani F
Bioorg Med Chem Lett; 2012 Apr; 22(7):2497-502. PubMed ID: 22405833
[TBL] [Abstract][Full Text] [Related]
12. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
Yun W; Ahmad M; Chen Y; Gillespie P; Conde-Knape K; Kazmer S; Li S; Qian Y; Taub R; Wertheimer SJ; Whittard T; Bolin D
Bioorg Med Chem Lett; 2011 Dec; 21(23):7205-9. PubMed ID: 22001092
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeability.
Bali U; Barba O; Dawson G; Gattrell WT; Horswill JG; Pan DA; Procter MJ; Rasamison CM; Sambrook Smith CP; Taylor-Warne A; Wong-Kai-In P
Bioorg Med Chem Lett; 2012 Jan; 22(2):824-8. PubMed ID: 22217874
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.
Lee K; Goo JI; Jung HY; Kim M; Boovanahalli SK; Park HR; Kim MO; Kim DH; Lee HS; Choi Y
Bioorg Med Chem Lett; 2012 Dec; 22(24):7456-60. PubMed ID: 23141914
[TBL] [Abstract][Full Text] [Related]
15. Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes.
McCoull W; Addie MS; Birch AM; Birtles S; Buckett LK; Butlin RJ; Bowker SS; Boyd S; Chapman S; Davies RD; Donald CS; Green CP; Jenner C; Kemmitt PD; Leach AG; Moody GC; Gutierrez PM; Newcombe NJ; Nowak T; Packer MJ; Plowright AT; Revill J; Schofield P; Sheldon C; Stokes S; Turnbull AV; Wang SJ; Whalley DP; Wood JM
Bioorg Med Chem Lett; 2012 Jun; 22(12):3873-8. PubMed ID: 22608962
[TBL] [Abstract][Full Text] [Related]
16. A pharmacologic increase in activity of plasma transaminase derived from small intestine in animals receiving an acyl CoA: diacylglycerol transferase (DGAT) 1 inhibitor.
Yokoyama H; Kobayashi A; Kondo K; Oshida SI; Takahashi T; Masuyama T; Shoda T; Sugai S
J Toxicol Sci; 2018; 43(2):135-157. PubMed ID: 29479035
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Collins CA; Voorbach MJ; Zhao G; Mittelstadt SW; Cox BF
Eur J Pharmacol; 2010 Jul; 637(1-3):155-61. PubMed ID: 20385122
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor.
Birch AM; Birtles S; Buckett LK; Kemmitt PD; Smith GJ; Smith TJ; Turnbull AV; Wang SJ
J Med Chem; 2009 Mar; 52(6):1558-68. PubMed ID: 19256504
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitors.
Kandre S; Bhagat PR; Reddy MM; Dalal R; Dixit A; Deshmukh NJ; Anthony J; Bose J; Anupindi R; Sharma R; Gupte A
Eur J Med Chem; 2014 May; 79():203-15. PubMed ID: 24735646
[TBL] [Abstract][Full Text] [Related]
20. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
